This Viewpoint reviews the Celgene settlement and provides a number of suggestions on how to move forward to address the safety and off-label marketing concerns that were litigated in the case.
from Cancer via ola Kala on Inoreader https://ift.tt/2rDeZE6
via IFTTT
Cancer Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου